Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2759 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 64.0 | 63 | |
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 1793.0 | 67 | |
N2759 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 119.5 | 64 | |
RA1869 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 67.0 | 47 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 61.0 | 43 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 118.5 | 42 | ||||
RA1931 | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 485.0 | 71 | ||||
RA1869 | PH-797804 | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 88.0 | 69 | |
RA1931 | PH-797804 | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 162.0 | 92 | |
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 58.0 | 64 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 57.0 | 57 | |
RA1931 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 63.5 | 60 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 54.0 | 61 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 103.5 | 54 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 68.0 | 65 | ||||
N2759 | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 1672.0 | 71 | ||||
N2586 | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 413.5 | 68 | ||||
RA1869 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 68.0 | 73 | |
N2759 | PH-797804 | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 987.0 | 68 | |
RA1931 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 119.0 | 68 | |
N2586 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 84.0 | 65 | |
N2586 | PH-797804 | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 129.0 | 80 | |
N2759 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 58.0 | 63 | |
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 517.0 | 69 | |
N2759 | Poly(I:C) | 2 | ug/mL | 1 | MIP-1B | 1277.0 | 48 |